Stephen Lyle

Operating Partner at Stage 1 Ventures LLC

Stephen Lyle

Stephen Lyle

Operating Partner at Stage 1 Ventures LLC

Biography

Stephen Lyle, MD, PhD

Vice President, Clinical Services and Laboratory Director

Prior to joining KEW, Dr. Lyle was a professor of pathology at the University of Massachusetts Medical Center and also served as lab director at Predictive Biosciences, medical director at Catalyst Oncology and laboratory site director for Ardais Corporation.

Overview
RelSci Relationships

236

Contact Data
Trying to get in touch with Stephen Lyle? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Stephen Lyle likely has professional access to. A relationship does not necessarily indicate a personal connection.

Operating Partner at Stage 1 Ventures LLC

Relationship likelihood: Strong

Operating Partner at Stage 1 Ventures LLC

Relationship likelihood: Strong

Co-Founder, Chief Technology Officer at Confirm, Inc.

Relationship likelihood: Strong

Investor at Eko Devices, Inc.

Relationship likelihood: Strong

Client Director at Cisco Systems, Inc.

Relationship likelihood: Strong

Partner at Foundersx LLC

Relationship likelihood: Strong

Venture Partner at LFV Management LLC

Relationship likelihood: Strong

Chief Executive Officer & Director at Wing Power Energy, Inc.

Relationship likelihood: Strong

President at Ucsd Alumni Association

Relationship likelihood: Strong

Executive Partner at Siris Capital

Relationship likelihood: Strong

Paths to Stephen Lyle
Potential Connections via
Relationship Science
You
Stephen Lyle
Operating Partner at Stage 1 Ventures LLC
Career History
Operating Partner
Current

Stage 1 Ventures focuses on investments in early-stage companies in the mobile, executable Internet, software-as-a-service (SaaS), IPTV, Internet video, pay-for performance marketing/advertising and security sectors.The firm targets companies that already have market-enabling internet protocol (IP) in place. Most of the firm's investments are in companies located in the Mid-Atlantic region of the US.

Vice President, Clinical Services & Laboratory Director
Prior

Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA.

Other Affiliations

Stephen Lyle is affiliated with Stage 1 Ventures LLC, Kew, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Stephen Lyle. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Stephen Lyle's profile does not indicate a business or promotional relationship of any kind between RelSci and Stephen Lyle.